DD270656A5 - Verfahren zur herstellung eines aeusserlich anwendbaren, antiviralen, in der haut akkumulierenden pharmazeutischen praeparates - Google Patents

Verfahren zur herstellung eines aeusserlich anwendbaren, antiviralen, in der haut akkumulierenden pharmazeutischen praeparates Download PDF

Info

Publication number
DD270656A5
DD270656A5 DD88316660A DD31666088A DD270656A5 DD 270656 A5 DD270656 A5 DD 270656A5 DD 88316660 A DD88316660 A DD 88316660A DD 31666088 A DD31666088 A DD 31666088A DD 270656 A5 DD270656 A5 DD 270656A5
Authority
DD
German Democratic Republic
Prior art keywords
deoxyuridine
preparation
antiviral
skin
pharmaceutical
Prior art date
Application number
DD88316660A
Other languages
German (de)
English (en)
Inventor
Anna Szabolcs
Laszlo Oetvoes
Janos Sagi
Helga Tuedoes
Attila Szemzoe
Zsuzsa Veres
Istvan Szinai
Miklos Vadja
Istvan Csernus
Katalin Marossy
Sandor Jancso
Eva Medgyesi
Gyoergy Bacsa
Original Assignee
������@��������@�������������@�������@����k��
��������@���������������@����������������������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@��������@�������������@�������@����k��, ��������@���������������@����������������������@���k�� filed Critical ������@��������@�������������@�������@����k��
Publication of DD270656A5 publication Critical patent/DD270656A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD88316660A 1987-08-07 1988-06-10 Verfahren zur herstellung eines aeusserlich anwendbaren, antiviralen, in der haut akkumulierenden pharmazeutischen praeparates DD270656A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873596A HU196038B (en) 1987-08-07 1987-08-07 Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine

Publications (1)

Publication Number Publication Date
DD270656A5 true DD270656A5 (de) 1989-08-09

Family

ID=10964716

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88316660A DD270656A5 (de) 1987-08-07 1988-06-10 Verfahren zur herstellung eines aeusserlich anwendbaren, antiviralen, in der haut akkumulierenden pharmazeutischen praeparates

Country Status (25)

Country Link
US (2) US4880785A (hu)
JP (1) JPS6442437A (hu)
KR (1) KR960015953B1 (hu)
CN (1) CN1034133A (hu)
AU (1) AU605875B2 (hu)
BE (1) BE1001774A4 (hu)
CA (1) CA1286227C (hu)
CH (1) CH675538A5 (hu)
CS (1) CS276467B6 (hu)
CY (1) CY1655A (hu)
DD (1) DD270656A5 (hu)
DE (1) DE3820270A1 (hu)
DK (1) DK299088A (hu)
ES (1) ES2010559A6 (hu)
FI (1) FI883692A (hu)
FR (1) FR2619010B1 (hu)
GB (1) GB2207864B (hu)
GR (1) GR1000139B (hu)
HU (1) HU196038B (hu)
IT (1) IT1217789B (hu)
NL (1) NL8801411A (hu)
NO (1) NO882491L (hu)
RU (1) RU2035180C1 (hu)
SE (1) SE503261C2 (hu)
SG (1) SG42292G (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918260A1 (de) * 1979-05-07 1980-11-27 Robugen Gmbh Anwendung von 5-alkyl-2'-desoxyuridinen
DE3010397A1 (de) * 1980-03-18 1981-10-29 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
WO1983000436A1 (en) * 1981-08-04 1983-02-17 Gauri, Kailash, Kumar Combined preparation with synergic effect
AU575918B2 (en) * 1984-03-06 1988-08-11 Sloan-Kettering Institute For Cancer Research Hepatitis treatment with pyrimidine nucleoside compounds
HU197837B (en) * 1984-12-29 1989-06-28 Mta Koezponti Kemiai Kutato In Composition with skin cleaning effect, particularly for treating pimpled skin of face

Also Published As

Publication number Publication date
CN1034133A (zh) 1989-07-26
GB2207864B (en) 1992-01-15
CS441388A3 (en) 1992-01-15
IT1217789B (it) 1990-03-30
DK299088A (da) 1989-02-08
HU196038B (en) 1988-09-28
US4937233A (en) 1990-06-26
AU605875B2 (en) 1991-01-24
CA1286227C (en) 1991-07-16
IT8820871A0 (it) 1988-06-06
CY1655A (en) 1993-05-14
JPS6442437A (en) 1989-02-14
SE8802193L (sv) 1989-02-08
NO882491L (no) 1989-02-08
GR1000139B (el) 1991-09-27
SE8802193D0 (sv) 1988-06-13
AU1741388A (en) 1989-02-09
ES2010559A6 (es) 1989-11-16
KR890003380A (ko) 1989-04-14
RU2035180C1 (ru) 1995-05-20
NL8801411A (nl) 1989-03-01
FR2619010A1 (fr) 1989-02-10
FI883692A (fi) 1989-02-08
CS276467B6 (en) 1992-06-17
GR880100417A (en) 1989-05-25
BE1001774A4 (fr) 1990-03-06
GB8813392D0 (en) 1988-07-13
US4880785A (en) 1989-11-14
DK299088D0 (da) 1988-06-02
SG42292G (en) 1992-09-04
FI883692A0 (fi) 1988-08-08
DE3820270A1 (de) 1989-02-16
FR2619010B1 (fr) 1992-02-14
SE503261C2 (sv) 1996-04-29
KR960015953B1 (ko) 1996-11-25
GB2207864A (en) 1989-02-15
JPH0515694B2 (hu) 1993-03-02
NO882491D0 (no) 1988-06-06
CH675538A5 (hu) 1990-10-15

Similar Documents

Publication Publication Date Title
DE69634733T2 (de) Benzamidoxime prodrugs und verwendung zur behandlung von pneumonie
DE3783024T2 (de) Topische ofloxacin enthaltende zubereitung.
DE4321444A1 (de) Pharmazeutische Zubereitung
DE3026180C2 (de) Rifamycin-SV-Salze von basischen Aminosäuren, Verfahren zu ihrer Herstellung und Arzneimittel zur intraartikulären Injektion bei der Bekämpfung von rheumatoider Arthritis
DD261095A5 (de) Verfahren zur herstellung von antiviralen kombinationen
EP0374096B1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
DE2900887A1 (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
EP0224868B1 (de) Primycin enthaltendes kolloidales Grundgel, Verfahren zu dessen Herstellung, dieses Grundgel enthaltende pharmazeutische und pharmako-kosmetische Kompositionen
DE2538573A1 (de) Uridine und diese enthaltende pharmazeutische praeparate
DD270656A5 (de) Verfahren zur herstellung eines aeusserlich anwendbaren, antiviralen, in der haut akkumulierenden pharmazeutischen praeparates
DD261094A5 (de) Verwendung der verbindung 1-beta-d-ribofuranosyl-1,2,4,-triazol-3-carbonsaeureamid zur herstellung einer pharmazeutischen zusammensetzung
DE3425466A1 (de) Synergistisches arzneimittelpraeparat zur behandlung von leberkrankheiten
DE2411823A1 (de) Verwendung von 1,2,4-triazol-3-carboxamiden und -thiocarboxamiden als antivirenmittel
DE3424997C2 (hu)
EP0403575B1 (de) Acyl-carnitin zur behandlung und zur verhütung von virusinfektionen
WO2000004884A1 (de) Arzneimittelzubereitungen zur topischen behandlung mukokutaner herpesinfektionen sowie der keratitis herpetica des auges
EP0024258A1 (de) Die Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Herpes-Infektionen
DE2625835A1 (de) Arzneimittel auf basis von adenosin-5'-thioaethern
DE2845762C2 (hu)
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
DE69715637T2 (de) Mit wasser mischbare monoglyceridester mit antimikrobieller aktivität
DE69725147T2 (de) Verfahren zur behandlung und vorbeugung von neurodegenerativen erkrankungen durch verabreichung von einem thiazolidin
EP1244442B1 (de) Verfahren zur auffindung von nukleotidsyntheseinhibitoren mit weniger nebenwirkungen
EP1663198A1 (de) Pharmazeutische formulierungen von xanthogenaten und hemmstoffen der viralen nukleinsäurereplikation (z.b. aciclovir)
DE2836560A1 (de) Antivirales mittel und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee